These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23525827)

  • 21. Sulforaphene attenuates multinucleation of pre-osteoclasts by suppressing expression of cell-cell fusion-associated genes DC-STAMP, OC-STAMP, and Atp6v0d2.
    Takagi T; Inoue H; Takahashi N; Katsumata-Tsuboi R; Uehara M
    Biosci Biotechnol Biochem; 2017 Jun; 81(6):1220-1223. PubMed ID: 28136694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.
    Ishii T; Ruiz-Torruella M; Ikeda A; Shindo S; Movila A; Mawardi H; Albassam A; Kayal RA; Al-Dharrab AA; Egashira K; Wisitrasameewong W; Yamamoto K; Mira AI; Sueishi K; Han X; Taubman MA; Miyamoto T; Kawai T
    FASEB J; 2018 Jul; 32(7):4016-4030. PubMed ID: 29533736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoclast stimulatory transmembrane protein (OC-STAMP), a novel protein induced by RANKL that promotes osteoclast differentiation.
    Yang M; Birnbaum MJ; MacKay CA; Mason-Savas A; Thompson B; Odgren PR
    J Cell Physiol; 2008 May; 215(2):497-505. PubMed ID: 18064667
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RANKL-induced DC-STAMP is essential for osteoclastogenesis.
    Kukita T; Wada N; Kukita A; Kakimoto T; Sandra F; Toh K; Nagata K; Iijima T; Horiuchi M; Matsusaki H; Hieshima K; Yoshie O; Nomiyama H
    J Exp Med; 2004 Oct; 200(7):941-6. PubMed ID: 15452179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sulforaphane inhibits osteoclast differentiation by suppressing the cell-cell fusion molecules DC-STAMP and OC-STAMP.
    Takagi T; Inoue H; Takahashi N; Katsumata-Tsuboi R; Uehara M
    Biochem Biophys Res Commun; 2017 Jan; 483(1):718-724. PubMed ID: 27979663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Regulates Osteoclast Differentiation via the Ca
    Chiu YH; Schwarz E; Li D; Xu Y; Sheu TR; Li J; de Mesy Bentley KL; Feng C; Wang B; Wang JC; Albertorio-Saez L; Wood R; Kim M; Wang W; Ritchlin CT
    J Cell Physiol; 2017 Sep; 232(9):2538-2549. PubMed ID: 27723141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strawberry notch homologue 2 regulates osteoclast fusion by enhancing the expression of DC-STAMP.
    Maruyama K; Uematsu S; Kondo T; Takeuchi O; Martino MM; Kawasaki T; Akira S
    J Exp Med; 2013 Sep; 210(10):1947-60. PubMed ID: 23980096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blocking of sodium and potassium ion-dependent adenosine triphosphatase-α1 with ouabain and vanadate suppresses cell-cell fusion during RANKL-mediated osteoclastogenesis.
    Makihira S; Nikawa H; Kajiya M; Kawai T; Mine Y; Kosaka E; Silva MJ; Tobiume K; Terada Y
    Eur J Pharmacol; 2011 Nov; 670(2-3):409-18. PubMed ID: 21945676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Luman is involved in osteoclastogenesis through the regulation of DC-STAMP expression, stability and localization.
    Kanemoto S; Kobayashi Y; Yamashita T; Miyamoto T; Cui M; Asada R; Cui X; Hino K; Kaneko M; Takai T; Matsuhisa K; Takahashi N; Imaizumi K
    J Cell Sci; 2015 Dec; 128(23):4353-65. PubMed ID: 26503158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inorganic phosphate-induced impairment of osteoclast cell-cell fusion by the inhibition of AP-1-mediated DC-STAMP expression.
    Arioka M; Takahashi-Yanaga F; Tatsumoto N; Sasaguri T
    Biochem Biophys Res Commun; 2017 Nov; 493(1):9-13. PubMed ID: 28939042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression.
    Zeng XZ; He LG; Wang S; Wang K; Zhang YY; Tao L; Li XJ; Liu SW
    Acta Pharmacol Sin; 2016 Feb; 37(2):255-63. PubMed ID: 26592521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of Osteoclast Differentiation by Myosin X.
    Tasca A; Astleford K; Lederman A; Jensen ED; Lee BS; Gopalakrishnan R; Mansky KC
    Sci Rep; 2017 Aug; 7(1):7603. PubMed ID: 28790434
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erucin inhibits osteoclast formation via suppressing cell-cell fusion molecule DC-STAMP without influencing mineralization by osteoblasts.
    Takagi T; Inoue H; Fujii S; Takahashi N; Uehara M
    BMC Res Notes; 2022 Mar; 15(1):105. PubMed ID: 35296341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ampelopsis brevipedunculata extract prevents bone loss by inhibiting osteoclastogenesis in vitro and in vivo.
    Kim JY; Park SH; Oh HM; Kwak SC; Baek JM; Lee MS; Rho MC; Oh J
    Molecules; 2014 Nov; 19(11):18465-78. PubMed ID: 25397737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DC-STAMP and TACE Levels are Higher in Patients with Periodontitis.
    Guardiola CJA; Clemente-Napimoga JT; Martinez EF; Abdalla HB; Peruzzo DC; Joly JC; Napimoga MH
    Braz Dent J; 2020; 31(2):122-126. PubMed ID: 32556010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mex3B inhibits DC-STAMP mRNA level and osteoclastogenesis.
    Yang Y; Wang SY; Li ZQ; Wu HN
    Cell Insight; 2022 Feb; 1(1):100002. PubMed ID: 37192984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells.
    Miyamoto H; Suzuki T; Miyauchi Y; Iwasaki R; Kobayashi T; Sato Y; Miyamoto K; Hoshi H; Hashimoto K; Yoshida S; Hao W; Mori T; Kanagawa H; Katsuyama E; Fujie A; Morioka H; Matsumoto M; Chiba K; Takeya M; Toyama Y; Miyamoto T
    J Bone Miner Res; 2012 Jun; 27(6):1289-97. PubMed ID: 22337159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Blimp1-Bcl6 axis is critical to regulate osteoclast differentiation and bone homeostasis.
    Miyauchi Y; Ninomiya K; Miyamoto H; Sakamoto A; Iwasaki R; Hoshi H; Miyamoto K; Hao W; Yoshida S; Morioka H; Chiba K; Kato S; Tokuhisa T; Saitou M; Toyama Y; Suda T; Miyamoto T
    J Exp Med; 2010 Apr; 207(4):751-62. PubMed ID: 20368579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring the impact of osteoprotegerin on osteoclast and precursor fusion: Mechanisms and modulation by ATP.
    Peng Y; Zhao H; Hu S; Ma Y; Han T; Meng C; Tong X; Zou H; Liu Z; Song R
    Differentiation; 2024; 138():100789. PubMed ID: 38896972
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of DC-STAMP in cellular fusion of osteoclasts and macrophage giant cells.
    Yagi M; Miyamoto T; Toyama Y; Suda T
    J Bone Miner Metab; 2006; 24(5):355-8. PubMed ID: 16937266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.